Arup Pramanik is a globally recognized healthcare executive who has spent 25 years transforming how innovation reaches patients. With deep expertise in market access, pricing strategy, and digital health, Arup has led major global initiatives across top pharmaceutical companies including Boehringer Ingelheim, Novartis, and Takeda. Known for uniting science with strategy, he has reshaped commercialization pathways through AI, real-world evidence, and value-based models—delivering outcomes that benefit both enterprise growth and health equity. Now preparing for board roles, Arup brings unmatched global insight, cross-sector leadership, and a bold vision for patient-centered innovation.

Excited to share my professional biography, highlighting my journey in global strategy, product launches, and commercialization within the pharmaceutical and biotech sectors. With over 25 years of experience, I've had the opportunity to work with extraordinary teams, driving growth and innovation across complex therapeutic areas. Here is my biography.